Carbondale, IL, United States of America

Chu Tsuchin

This inventor holds 1 USPTO granted patent. Top assignee: Clipius Technologies, Inc.. Active years: 2011.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chu Tsuchin in Biopsy Technology

Introduction

Chu Tsuchin is an accomplished inventor based in Carbondale, IL (US). He has made significant contributions to the field of medical instrumentation, particularly in biopsy technology. His innovative approach has led to the development of a unique biopsy needle that enhances the efficiency of tissue sample collection.

Latest Patents

Chu Tsuchin holds 1 patent for his invention titled "Double core biopsy instrumentation kit." This patent describes a biopsy needle designed to collect tissue samples effectively. The needle features a first cavity for accepting a first sample core and a second cavity for a second sample core. Additionally, it includes a sheath with a single slot or opening, positioned coaxially with the needle. This design allows for improved sample collection and may be accompanied by a separate core extraction kit.

Career Highlights

Chu Tsuchin is currently associated with Clipius Technologies, Inc., where he continues to innovate in the medical field. His work focuses on developing advanced tools that facilitate better diagnostic procedures. His dedication to improving medical technology has made a notable impact on the industry.

Collaborations

Some of his coworkers include Thomas Tarter and Julie Tarter, who contribute to the collaborative environment at Clipius Technologies, Inc. Their combined expertise fosters innovation and drives the development of new medical solutions.

Conclusion

Chu Tsuchin's contributions to biopsy technology exemplify the importance of innovation in the medical field. His patented inventions are paving the way for more effective diagnostic tools, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…